Augmented Berlin-Frankfurt-Munster Therapy Plus Ofatumumab for Young Adults With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
Clinical trial NCT02419469 · TERMINATED
Trial details
- NCT number
- NCT02419469
- Sponsor
- M.D. Anderson Cancer Center
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-11-13
- Primary completion
- 2017-06-22
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.